Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moleculin Biotech CS
(NQ:
MBRX
)
2.580
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.580
Bid (Size)
1.040 (2)
Ask (Size)
2.930 (1)
Prev. Close
2.580
Today's Range
2.580 - 2.580
52wk Range
2.115 - 15.75
Shares Outstanding
2,227,516
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Insights Ahead: Moleculin Biotech's Quarterly Earnings
November 07, 2024
Via
Benzinga
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024
August 14, 2024
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-81.39%
-81.39%
1 Month
+2.79%
+2.79%
3 Month
+9.32%
+9.32%
6 Month
-40.14%
-40.14%
1 Year
-65.98%
-65.98%
More News
Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 14, 2024
Via
Benzinga
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024
May 10, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
Moleculin Biotech (NASDAQ:MBRX) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
April 25, 2024
Via
ACCESSWIRE
MBRX Stock Earnings: Moleculin Biotech Reported Results for Q4 2023
March 22, 2024
Via
InvestorPlace
A Preview Of Moleculin Biotech's Earnings
March 21, 2024
Via
Benzinga
Moleculin Biotech's Earnings: A Preview
November 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 08, 2024
Via
Benzinga
Earnings Scheduled For March 22, 2024
March 22, 2024
Via
Benzinga
Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
March 20, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
March 04, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 24, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 09, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 30, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 28, 2023
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 22, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 21, 2023
Via
Benzinga
Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
November 13, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
